NIH-funded research NIH-funded research

Creating a new model to study Frontotemporal Dementia caused by MAPT mutations

Official title: iPSC-based Model to Study Frontotemporal Dementia Due to MAPT Mutation

Funded at Regenerative Research Foundation · NIH-11121463 · Data updated 2026-11-12

This study is creating a special 3D model of brain cells to help us understand how a specific gene mutation related to Frontotemporal Dementia affects the brain, which could lead to new ways to treat the condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRegenerative Research Foundation
NIH-funded
Lab location1 site (Albany, UNITED STATES)
Project startJune 1, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$1,540,579
NIH project number1RF1NS142335-01
Project IDNIH-11121463 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with Frontotemporal Dementia linked to MAPT gene mutations.

Less likely to help

Patients with Frontotemporal Dementia not associated with MAPT mutations may not benefit from this research.

What this research studies

This research aims to develop a complex 3D cellular model to better understand Frontotemporal Dementia (FTD) resulting from mutations in the MAPT gene. By generating organoids that replicate the brain's structure, including the cerebral cortex, striatum, and midbrain, the study will investigate how abnormal tau protein accumulation affects brain cells and leads to cognitive and behavioral symptoms. This model will allow researchers to observe the interactions between different brain regions and how they contribute to the disease's progression, potentially leading to new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with Frontotemporal Dementia.

How similar studies have gone: Previous research has shown promise in using 3D cellular models to study tauopathies, indicating that this approach could yield valuable insights.

Where this research is happening

  • Regenerative Research Foundation
    Albany, United States
    Active

Researchers

  • Principal investigator: Temple, Sally — Regenerative Research Foundation
  • Study coordinator: Temple, Sally

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.